MEK1/2 (D1A5) Rabbit mAb and 9 more items

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, awarded a purchase order (PO) contract to Cell Signaling Technology Inc. on October 2, 2025, with a total contract value of $3,622. The contract covers the procurement of ten distinct research-grade antibodies and reagents, primarily focused on cellular signaling and research applications. Product lines include MAPK (Mitogen-Activated Protein Kinase) antibodies, JNK (c-Jun N-terminal Kinases) antibodies, phosphorylation state-specific protein markers, and an Autophagy Antibody Sampler Kit.

The contract specifies delivery to UNMC Shipping and Receiving, with a designated unloading point at location BCC 6.12.424, and has a brief performance period from October 2 to October 8, 2025. Individual line items range in unit price from $87 for MG-132 to $625 for the Autophagy Antibody Sampler Kit. The purchase is structured with Net 30 payment terms, F.O.B. destination with prepaid freight, and leverages the university's tax-exempt status under number 05-8905401. The scientific reagents appear intended for research purposes, likely supporting ongoing medical or biological research initiatives at the University of Nebraska Medical Center.